Literature DB >> 10230701

Survival of human parathyroid tissue xenotransplanted in nude mice after 9 to 55 months' cryopreservation.

S Smeds1, L Trulsson, M Garovoy, M Gumbert, O H Clark.   

Abstract

Survival of human parathyroid tissue xenotransplanted after cryopreservation was studied. Peroperative biopsies from 26 patients were cryopreserved and xenotransplanted into nude mice after 9 to 55 months. At 8 to 12 weeks after transplantation, the morphology of the transplanted tissue was compared to that of the original tissue after thawing and before transplantation. Morphologically viable tissue was observed in 20 out of 26 nude mice (77%). Based on the morphological appearance, the parathyroid transplants were arranged into four "quality" groups. No correlation existed between the quality of the transplants and duration of storage, or between the age and sex of the patients. There was no correlation between initial clinical diagnosis or histopathological patterns (primary, secondary and tertiary hyperplasia [n=16], adenoma [n=9], one case undetermined) and transplant survival. After thawing and transplantation, all parathyroid grafts, except one, were morphologically either of the same or somewhat lower quality.

Entities:  

Mesh:

Year:  1999        PMID: 10230701     DOI: 10.1111/j.1699-0463.1999.tb01579.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  2 in total

1.  Viability of cryopreserved parathyroid tissue: when is continued storage versus disposal indicated?

Authors:  Marlon A Guerrero; Douglas B Evans; Jeffrey E Lee; Ruijun Bao; Abby Bereket; Swaroop Gantela; Gary D Griffin; Nancy D Perrier
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

2.  Successful Secondary Engraftment of Pancreatic Ductal Adenocarcinoma and Cholangiocarcinoma Patient-Derived Xenografts After Previous Failed Primary Engraftment.

Authors:  Matthew C Hernandez; Lin Yang; Jennifer L Leiting; Takaaki Sugihara; John R Bergquist; Tommy Ivanics; Rondell Graham; Mark J Truty
Journal:  Transl Oncol       Date:  2018-09-28       Impact factor: 4.243

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.